Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Advanced Cancers 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
LY 2275796 × Clear all
NCT01675128 2016-04-25

ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
24 enrolled 21 charts
Gastrointestinal

Colorectal Neoplasms

NCT00903708 2012-07-30

LY2275796 in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
24 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡